Axsome Therapeutics to Present New Sunosi® Data at SLEE

Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apneaNEW YORK, June 01, 2023 -- Axsome Therapeutics, Inc. , a... | June 1, 2023

Related Keywords

Germany , United Kingdom , Japan , United States , China , New York , British , American , German , Darren Opland , Hans Van Dongen , Johannes Gutenberg , Mark Jacobson , Russell Rosenberg , Research Society , World Trade Center , Drug Administration , Neurotrials Research , Nasdaq , Corporate Communications , Professor At Washington State University , Us Drug Enforcement Agency On , Sk Biopharmaceuticals Co Ltd , Axsome Therapeutics Inc , Medicine Center , American Academy Of Sleep Medicine , Department Of Neurology , American Academy , Sleep Medicine , Sleep Research Society , Cognitive Health , Apnea Participants During , Randomized Placebo Controlled , Washington State University , Obstructive Sleep Apnea , Excessive Daytime Sleepiness , Board Number , Follow Up Experience , Yaroslav Winter , Mainz Comprehensive Epilepsy , Sleep Medicine Center , Johannes Gutenberg University , Excessive Sleepiness , Effect Sizes , Numbers Needed , Healthcare Resource Utilization Burden , Gregory Parks , Randomized Placebo Controlled Study , Digit Symbol Substitution Test , Repeatable Battery , Neuropsychological Status , Digit Symbol Substitution , British Columbia Cognitive Complaints Inventory , Patient Global Impression , Epworth Sleepiness Scale , Real World Experience , Enforcement Agency , Full Prescribing Information , Medication Guide , Axsome Therapeutics , Nc Stock Exchange , News , Information , Press Release , Cognitive , Improvement , Ith , Vsunosi , Sustained , Dover , Flight , Tours , N , Patients , Excessive , Daytime , Sleepiness , Ue , O , Obstructive , Sleep , Pneanew , Pune , 023 , Xsome Axsm Us05464t1043 ,